PREVALENCE OF MUTATIONS IN EGFR, KRAS AND BRAF IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AS ASSESSED BY A PANEL OF PCR-BASED ASSAYS

被引：0
|
作者：
O'Donnell, Patrick
Current, Robert
Ferguson, Jane
Chien, Shih-Chang
Wen, Wei
Tsan, Alison
Newton, Nick
Jung, Laura
Bauer, Keith
Langland, Rachel
Brophy, Victoria
Schoenbrunner, Nancy
Myers, Thomas
Soviero, Stephen
Lawrence, Jeffrey
Wu, Lin
机构：
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; Kras mutations; BRAF mutations; molecular diagnostics;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1533 / S1534
页数：2
相关论文
共 50 条
  • [1] POPULATION BASED STUDY OF THE PREVALENCE OF EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Skov, Birgit G.
    Hogdall, Estrid
    Clementsen, Paul
    Krasnik, Mark
    Larsen, Klaus R.
    Sorensen, Jens B.
    Mellemgaard, Anders
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1082 - S1083
  • [2] PREDICTIVE VALUE OF KRAS AND BRAF MUTATIONS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH CHEMOTHERAPY
    Dingemans, Anne-Marie
    Smit, Egbert F.
    Heideman, Danielle
    Mellema, Wouter
    Derks, Jules
    Van, Robertjan Suylen
    Thunnissen, Erik
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1044 - S1044
  • [3] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Kim, Seung Tae
    Sung, Jae Sook
    Jo, Uk Hyun
    Park, Kyong Hwa
    Shin, Sang Won
    Kim, Yeul Hong
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [4] Can mutations of EGFR and KRAS in serum be predictive and prognostic markers in patients with advanced non-small cell lung cancer (NSCLC)?
    Seung Tae Kim
    Jae Sook Sung
    Uk Hyun Jo
    Kyong Hwa Park
    Sang Won Shin
    Yeul Hong Kim
    Medical Oncology, 2013, 30
  • [5] CAN MUTATIONS OF EGFR AND KRAS OF SERUM BE PREDICTIVE AND PROGNOSTIC MARKERS IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)?
    Kim, S. T.
    Kim, Y. H.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S66 - S66
  • [6] Prevalence of EGFR mutations in patients with Non-Small Cell Lung Cancer (NSCLC) in Turkish population
    Sener, E.
    Kosemehmetoglu, K.
    Tezel, G. Guler
    VIRCHOWS ARCHIV, 2013, 463 (02) : 320 - 320
  • [7] PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer
    Dahse, Regine
    Berndt, Alexander
    Kosmehl, Hartwig
    ANTICANCER RESEARCH, 2008, 28 (4B) : 2265 - 2270
  • [8] Prevalence of EGFR mutations in non-small cell lung cancer (NSCLC) smoker patients.
    Izarzugaza, Yann
    Domine, Manuel
    Rojo, Federico
    Casado, Victoria
    Leon, Ana
    Jesus Fernandez-Acenero, Maria
    Rubio, Gustavo
    Cordova, Sharon
    Madoz, Juan
    Ignacio Martin-Valades, Jose
    Luis Arranz, Juan
    Serrano, Gloria
    Carames, Cristina
    Zazo, Sandra
    Rincon, Raul
    Canadas, Carmen
    Perez-Gonzalez, Nuria
    Campos, Angel
    Lobo, Francisco
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Development of multiplexed Absolute Q digital PCR assays to rapidly quantify EGFR and KRAS genotype in advanced non-small cell lung cancer (NSCLC) patients' plasma
    Hanna, Benjamin
    Xu, Shidong
    Paweletz, Cloud P.
    Kuang, Yanan
    CANCER RESEARCH, 2024, 84 (06)
12345